HLOSF
HEALIOS K K by HEALIOS K K (HLOSF)
$10
About HEALIOS K K by HEALIOS K K (HLOSF)
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. It develops therapies for ischemic stroke, acute respiratory distress syndrome, liver disease, and age-regulated macular degeneration. The company was founded by Tadahisa Kagimoto on February 24, 2011 and is headquartered in Tokyo, Japan.
Details
Daily high
$2.10
Daily low
$2.10
Price at open
--
52 Week High
$4.45
52 Week Low
$0.96
Market cap
243.0M
Dividend yield
0.00%
Volume
500
Avg. volume
37
P/E ratio
-7.95
HEALIOS K K by HEALIOS K K News
Details
Daily high
$2.10
Daily low
$2.10
Price at open
--
52 Week High
$4.45
52 Week Low
$0.96
Market cap
243.0M
Dividend yield
0.00%
Volume
500
Avg. volume
37
P/E ratio
-7.95